Cardiac allograft vasculopathy
Disease1 paper2 findings
- Humans1
Associations
1Delta age
upin humans1OR 1.138
1 study
Delta age
upin humans1OR 1.138
Cardiac allograft vasculopathy is associated with delta age in humans (median -1.0 vs. -11.0 years).
Humansheart transplant recipients
Discharge AI-ECG-Derived Age and Incidence of Cardiac Allograft Vasculopathy at 3 Years: A Pilot Study · Journal of cardiovascular development and disease · 20 Aug 2026
Delta age predicts cardiac allograft vasculopathy in humans (adjusted OR 1.138, 95% CI 1.023-1.265).
Humanspost-transplant discharge
Discharge AI-ECG-Derived Age and Incidence of Cardiac Allograft Vasculopathy at 3 Years: A Pilot Study · Journal of cardiovascular development and disease · 20 Aug 2026
Trial sponsors
Institute for Clinical and Experimental Medicine
1 trialPhase 4126 people
1 trialPhase 3211 people
Ottawa Heart Institute Research Corporation
1 trialPhase 3135 people
1 trialPhase 3130 people
1 trialPhase 3100 people
1 trialPhase 218 people